Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
18 June 2024 - preview of changes for July 2024
Pharmaceutical |
Change |
---|---|
Abacavir sulphate oral liq 20 mg per ml |
new listing |
Adalimumab (Humira – alternative brand) |
new Pharmacode listing (p’code 2635003) |
Adenosine inj 3 mg per ml, 2 ml vial |
Brand change
|
Adenosine inj 3 mg per ml, 10 ml vial (Adenosine Baxter) |
new listing and addition of PSS (p’code 2655780) |
Adrenaline (DBL Adrenaline) inj 1,000, 1 ml |
price increase |
Amikacin (DBL Amikacin) inj 250 mg per ml, 2 ml vial |
price decrease and addition of PSS |
Amisulpride (Sulprix) tab 100 mg, 200 mg and |
price decrease and addition of PSS |
Amoxicillin with clavulanic acid (Augmentin) grans for oral liq 25 mg with clavulanic acid 6.25 mg per ml, 100 ml |
price increase |
Amoxicillin with clavulanic acid (Cerobact) inj 1,000 mg with clavulanic acid 200 mg vial |
new listing (p’code 2676834) |
Aripiprazole (Abilify Maintena) inj 300 mg vial and 400 mg vial |
new listing
|
Atorvastatin (Lorstat) tab 10 mg, 20 mg, 40 mg and 80 mg |
price decrease and addition of PSS |
Bacillus calmette-guerin vaccine (BCG Vaccine AJV) inj |
amended brand name and addition of PSS |
Baclofen (Pacifen) tab 10 mg |
price decrease and addition of PSS |
Bedaquiline (Sirturo) tab 100 mg, 188 tab pack |
revoke delisting |
Betamethasone dipropionate with calcipotriol (Daivobet) gel 500 mcg with calcipotriol 50 mcg |
price increase and addition of PSS |
Betamethasone dipropionate with calcipotriol (Daivobet) oint 500 mcg with calcipotriol 50 mcg per g, 30 g |
price decrease and addition of PSS |
Brimonidine tartrate with timolol maleate (Combigan) eye drops 0.2% with timolol 0.5%, 5 ml |
amended chemical name, new listing and |
Brinzolamide (Azopt) eye drops 1%, 5 ml |
price decrease and addition of PSS |
Buspirone (Buspirone Viatris) tab 5 mg |
price decrease and addition of PSS |
Buspirone (Buspirone Viatris) tab 10 mg |
addition of PSS |
Carbamazepine (Tegretol AU) tab 200 mg |
new listing (p’code 2681331) |
Carboplatin inj 10 mg per ml, 45 ml vial |
Brand change
|
Cefepime inj 1 g vial and 2 g vial |
Brand change Cefepime-AFT – new listing and addition of PSS
Cefepime Kabi to be delisted 1 December 2024 |
Cinacalcet (Cinacalcet Devatis) tab 30 mg and |
price decrease and addition of PSS
|
Ciprofloxacin tab 750 mg
|
Brand change
|
Cisplatin inj 1 mg per ml, 100 ml vial
|
Brand change
|
Clindamycin (Dalacin C) cap 150 mg |
price decrease and addition of PSS |
Covid-19 vaccine (Comirnaty Omicron (XBB.1.5)) inj 10 mcg raxtozinameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap |
new listing (p’code 2682346) |
Covid-19 vaccine (Comirnaty Omicron (XBB.1.5)) inj 3 mcg raxtozinameran per 0.2 ml, 0.4 ml vial; |
new listing (p’code 2682354) |
Covid-19 vaccine (Comirnaty Omicron (XBB.1.5)) inj 30 mcg raxtozinameran per 0.3 ml 2.25 ml vial; adult vaccine, dark grey cap |
new listing (p’code 2682311) |
Covid-19 vaccine (Comirnaty Omicron (XBB.1.5)) inj 30 mcg raxtozinameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap |
new listing (p’code 2682338) |
Cyclophosphamide (Cyclonex) tab 50 mg |
addition of PSS |
Daunorubicin (Daunorubicin Zentiva) inj 20 mg vial |
delisted 1 July 2024 |
Diabetic oral feed 1 kcal/ml (Diasip (strawberry and vanilla) liquid 4.9 g protein, 11.7 g carbohydrate, 3.8 g fat and 2 g fibre per 100 ml, 200 ml bottle |
new listing
|
Diphtheria, tetanus and pertussis vaccine (Boostrix) inj |
amended presentation description and addition of PSS |
Diphtheria, tetanus, pertussis and polio vaccine |
addition of PSS |
Diphtheria, tetanus, pertussis, polio, hepatitis b and haemophilus influenzae type B vaccine (Infanrix-hexa) inj |
amended presentation description and addition of PSS |
Dobutamine (Dobutamine-hameln) inj 12.5 mg per ml, 20 ml ampoule |
addition of PSS |
Eplerenone (Inspra) tab 25 mg |
price decrease and addition of PSS |
Eplerenone (Inspra) tab 50 mg |
addition of PSS |
Fentanyl (Fentanyl Sandoz) patch 12.5 mcg per hour, 25 mcg per hour, 50 mcg per hour, 75 mcg per hour and 100 mcg per hour |
price decrease and addition of PSS |
Ferrous fumarate with folic acid (Ferro-F-Tabs) tab 310 mg (100 mg elemental) with folic acid 350 mcg |
addition of PSS |
Filgrastim (Nivestim) inj 300 mcg in 0.5 ml prefilled syringe and 480 mcg in 0.5 ml prefilled syringe |
price decrease and addition of PSS |
Flumazenil inj 0.1 mg per ml, 5 ml ampoule
|
Brand change
|
Fluorouracil (Fluorouracil Accord) inj 50 mg per ml, 20 ml vial |
addition of PSS |
Fluorouracil (Fluorouracil Accord) inj 50 mg per ml, 100 ml vial |
price decrease and addition of PSS |
Fluorouracil sodium (Efudix) crm 5%, 20 g |
price decrease and addition of PSS |
Glycomacropeptide and amino acid contains some phenylalanine (Glytactin Bettermilk) powder |
amended brand name |
Glycomacropeptide and amino acid contains some phenylalanine (PKU Build 10, PKU Build 20 Chocolate, Raspberry Lemonade, Smooth, Vanilla and PKU Glytactin RTD 15) powder |
amended presentation description |
Haemophilus influenzae type b vaccine (Act-HIB) inj 10 mcg vial with diluent syringe |
new listing and addition of PSS (p’code 2404699) |
Heparin sodium
|
price increase |
Heparinised saline (Pfizer) inj 10 iu per ml, 5 ml ampoule |
price increase |
Hepatitis A vaccine (Havrix 1440) inj 1440 ELISA units in 1 ml syringe |
amended brand name and addition of PSS |
Hepatitis A vaccine (Havrix Junior) inj 720 ELISA units in 0.5 ml syringe |
addition of PSS |
Hepatitis B recombinant vaccine (Engerix-B) inj 10 mcg per 0.5 ml prefilled syringe and 20 mcg per |
addition of PSS |
Human papillomavirus (6, 11, 16, 18, 31, 33, 45, 52 and 58) vaccine [HPV] (Gardasil) inj 270 mcg in |
amended restriction criteria and addition of PSS |
Hydrocortisone (Solu-Cortef) inj 100 mg vial |
price decrease and addition of PSS |
Ipratropium bromide (Ipratropium IVAX) nebuliser soln 250 mcg per ml, 2 ml ampoule |
new listing (p’code 2680815) |
Isotretinoin (Oratane) cap 5 mg, 10 mg and 20 mg |
addition of PSS |
Ketamine (Ketalar) inj 100 mg per ml, 2 ml vial |
price increase |
Letrozole (Letrole) tab 2.5 mg |
price decrease and addition of PSS |
Linezolid (Linezolid Kabi) inj 2 mg per ml, 300 ml bottle |
addition of PSS |
Linezolid (Zyvox) tab 600 mg |
price decrease and addition of PSS |
Lomustine (Medac) cap 40 mg |
new listing (p’code 2681137) |
Measles, mumps and rubella vaccine (Priorix) inj |
addition of PSS |
Mebendazole (Vermox) tab 100 mg |
price decrease and addition of PSS |
Medroxyprogesterone (Provera HD) tab 100 mg |
price increase |
Medroxyprogesterone acetate (Provera) tab 2.5 mg, 5 mg and 10 mg |
price increase |
Melatonin (Vigisom) tab modified-release 2 mg |
price decrease and addition of PSS |
Meningococcal (A, C, Y and W-135) conjugate |
addition of PSS |
Meningococcal (A, C, Y and W-135) conjugate |
new listing (p’code 2506971) |
Meningococcal C conjugate vaccine (Neisvac-C) inj 10 mcg in 0.5 ml syringe |
to be delisted 1 December 2024 |
Mercaptopurine (Xaluprine) oral suspension 20 mg per ml, 100 ml |
new listing (p’code 2682257) |
Methotrexate (Trexate) tab 2.5 mg and 10 mg |
price decrease and addition of PSS |
Midostaurin (Rydapt) cap 25 mg |
new listing (p’code 2608650) |
Milrinone (Milrinone-Baxter) inj 1 mg per ml, 10 ml ampoule |
price decrease and addition of PSS |
Nicotine (Habitrol)
|
price increase |
Nitrofurantoin (Nifuran) tab 50 mg |
addition of PSS |
Octreotide inj depot 10 mg prefilled syringe and 20 mg prefilled syringe |
Brand change Sandostatin LAR – new listing and
Octreotide Depot Teva to be delisted 1 December 2024 |
Octreotide (Sandostatin LAR) inj depot 30 mg prefilled syringe |
addition of PSS |
Oestradiol (Lyllana) patch 25 mcg per day, 50 mcg per day, 75 mcg per day and 100 mcg per day |
new listing
|
Olanzapine (Zypine) tab 2.5 mg, 5 mg and 10 mg, 28 tab pack |
delay delisting until 1 January 2025 |
Oral feed 1.5 kcal/ml (Fortisip (banana, chocolate, strawberry and vanilla) liquid 6 g protein, 18.4 g carbohydrate and 5.8 g fat per 100 ml, 200 ml |
new listing
|
Oral feed with fibre 1.5 kcal/ml (Fortisip Multi Fibre (chocolate, strawberry and vanilla)) liquid 6 g protein, 18.4 g carbohydrate, 5.8 g fat and 2.3 g fibre per 100 ml, 200 ml bottle |
new listing
|
Oxycodone hydrochloride (Hameln) inj 10 mg per ml, 1 ml ampoule, inj 10 mg per ml, 2 ml ampoule, inj 50 mg per ml, 1 ml ampoule |
price decrease and addition of PSS |
Oxycodone hydrochloride (Oxycodone Amneal) |
new listing
|
Oxycodone hydrochloride (Oxycodone Sandoz) tab controlled-release 5 mg, 10 mg and 20 mg |
price decrease and addition of PSS |
Oxycodone hydrochloride (Oxycodone Sandoz) tab controlled-release 40 mg |
price increase and addition of PSS |
Oxycodone hydrochloride (Oxycodone Sandoz) tab controlled-released 80 mg |
addition of PSS |
Palbociclib (Ibrance) tab 75 mg, 100 mg and 125 mg |
amended restriction criteria |
Parecoxib (Dynastat) inj 40 mg vial |
price decrease and addition of PSS |
Perindopril (Coversyl) tab 2 mg |
price increase and addition of PSS |
Perindopril (Coversyl) tab 4 mg and 8 mg |
price decrease and addition of PSS |
Pioglitazone (Vexazone) tab 15 mg, 30 mg and |
price decrease and addition of PSS |
Pneumococcal (PCV13) conjugate vaccine |
addition of PSS |
Pneumococcal (PPV23) polysaccharide vaccine (Pneumovax 23) inj |
addition of PSS |
Poliomyelitis vaccines (IPOL) inj 80 D-antigen units in 0.5 ml syringe |
addition of PSS |
Prednisolone (Redipred) oral liq 5 mg per ml, 30 ml |
addition of PSS |
Prednisolone sodium phosphate (Minims Prednisolone) eye drops 0.5%, single dose (preservative free), 20 dose |
price increase |
Ribociclib (Kisqali) tab 200 mg |
new listing
|
Rifaximin (Xifaxan) tab 550 mg |
addition of PSS |
Rotavirus oral vaccine (Rotarix) oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator |
addition of PSS |
Salbutamol (Ventolin) aerosol inhaler, 100 mcg per dose, 200 dose |
price increase |
Salbutamol with ipratropium bromide (Duolin Cipla) nebuliser soln 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml |
new listing (p’code 2680807) |
Sildenafil (Vedafil) tab 25 mg and 50 mg |
price decrease and addition of PSS |
Sildenafil (Vedafil) tab 100 mg |
price increase and addition of PSS |
Sodium hyaluronate [hyaluronic acid] (Hylo-Fresh) eye drops 1 mg per ml, 10 ml |
price decrease and addition of PSS |
Sugammadex (Sugammadex BNM) inj 100 mg per ml, 2 ml vial and 5 ml vial |
price decrease and addition of PSS |
Sulfadiazine silver (Ascend) crm 1%, 50 g |
new listing (p’code 2682435) |
Sulfadiazine sodium (e.g.Sulfadiazine-Heyl; Wockhardt) tab 500 mg |
new example brand listing |
Ticagrelor (Ticagrelor Sandoz) tab 90 mg |
price decrease and addition of PSS |
Tobramycin (Tobramycin (Viatris)) inj 40 mg per ml, 2 ml vial |
price decrease and addition of PSS |
Travoprost (Travatan) eye drops 0.004%, 2.5 ml |
price decrease and addition of PSS |
Trimethoprim with sulphamethoxazole |
price increase |
Tuberculin PPD [Mantoux] text (Tubersol) inj 5 TU per 0.1 ml, 1 ml vial |
addition of PSS |
Varicella vaccine [chickenpox vaccine] (Varilrix) inj 2000 PFU prefilled syringe, 10 inj pack |
new listing and addition of PSS (p’code 2678950) |
Varicella zoster vaccine [shingles vaccine] |
amended restriction criteria |
Zoledronic acid (Zoledronic acid Viatris) inj 4 mg per 5 ml, vial |
price decrease and addition of PSS |
|
|